GlassScriptPhysician profile
Ajaykumar N Amin
NPI 1437302007
$10,413.47
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.44 · 2020: $16.69 · 2021: $102 · 2022: $8,644 · 2023: $1,467 · 2024: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,375 · Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,375.00 |
| Food and Beverage | $229.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10,061.09 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $132.33 | 2019-2024 | |
| Hologic Sales and Service, LLC | $50.68 | 2021-2024 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Shield Therapeutics INC | $49.54 | 2024 | |
| Mayne Pharma Commercial LLC | $40.69 | 2023 | |
| Novo Nordisk INC | $40.27 | 2024 | |
| Alkermes, INC. | $23.87 | 2022 | |
| Cranial Technologies, INC | $15.00 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajaykumar Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.